What does InMode's acquisition mean for Morpheus8 handpiece pricing?

PE ownership typically leads to margin compression for practices through higher consumable costs and stricter rebate terms. Practice owners should expect potential increases in handpiece pricing and service-contract costs post-close, particularly if the buyer pursues aggressive margin optimization.

Will InMode's loyalty programs change after a PE acquisition?

Yes, loyalty-program changes are a common post-acquisition risk. PE buyers typically restructure rebate terms and service contracts to improve margins, so practices should review current agreements and lock in favorable terms before any deal closes.

How many practices currently use InMode's Morpheus8 and energy devices?

InMode's core products are installed in thousands of US practices and generate recurring revenue through handpiece sales and service contracts. The exact number of installed systems is not publicly disclosed, but the installed base is substantial enough to make InMode an attractive acquisition target.

What is Steel Partners' acquisition offer price for InMode?

Steel Partners submitted a $16.75-per-share cash offer for InMode. InMode's board committee is currently evaluating rival proposals in a competitive auction process, so the final acquisition price may differ from this initial bid.

What typically happens to service contracts and support after a PE acquisition of a med device company?

PE buyers often restructure service contracts and support terms to optimize margins and consolidate operations. Practices should anticipate potential changes to service-contract pricing, response times, and support availability post-close.

Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →

RegulatoryAbbVie Launches Phase 2 Forehead Lines Studytoday MarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days ago Business & M&AAllergan Aesthetics Overhauls Loyalty Programtoday Devices & TechXERF Technology Enters Australian Market for Skin Tightening2 days ago Business & M&AEvolus Expands Estyme to Canada, Australia, New Zealandtoday MarketArm Fat Now Top Body Sculpting Concern in Singapore2 days ago Devices & TechSofwave Hits One Million Treatments Milestonetoday RegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days ago RegulatoryRevance Wins FDA Nod for Under-Eye Injectablesyesterday MarketGLP-1 Pill Era Is Forcing Beauty Market Shiftyesterday InjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Datayesterday Devices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday

Business & M&A

Steel Partners Offers to Acquire InMode at $16.75 Per Share; Board Evaluates Rival Bids

PE firm's cash offer for RF microneedling and energy-device leader triggers competitive auction process.

By Evan at Inside MedSpa · Jul 22, 2026

1-YEAR MOVE

INMD ▲1.0%

1-year price move by ticker
Ticker	Company	1-year change
INMD	InMode Ltd.	+1.0%

Steel Partners submitted a $16.75-per-share cash acquisition offer for InMode, the Israeli RF microneedling and energy-device manufacturer. InMode's board committee is evaluating rival proposals, signaling a competitive auction. InMode's core products—Morpheus8 (fractional RF microneedling) and Lumenis-legacy energy platforms—are installed in thousands of US practices and generate recurring revenue through handpiece sales and service contracts.

Inside MedSpa Pro

You've reached your free articles this week.

Keep reading every article, unlock the full trackers, and get the twice-a-week intelligence brief — from $20/mo, or $200/yr (two months free). Never miss a recall or a rule change.

Every article, unlocked — no weekly limit
The full 50-state law tracker, stock & M&A watch
The twice-a-week, 2-minute intelligence brief
Recalls, FDA clearances & safety signals as they hit

See everything you get →

Cancel anytime, one click · 14-day money-back on annual

https://insidemedspa.com/article/steel-partners-inmode-acquisition-offer-16-75/

Discussion

Free alerts

Get flagged before it costs you.

We'll flag the moment a recall or rule change hits your practice. One email a week, one click to leave.

Free · weekly · unsubscribe anytime. Privacy.

This morning's brief · 6 AM

The free version stops here.

What today's moves mean for your margins — and exactly what to do — already went out to Pro. By the time the trade press explains it, the window to act has closed.

Go Pro · $20/mo Two minutes a morning. Cancel anytime.

Live · Market movers

STRATA Skin Sciences-50%Hims & Hers Health+6.03%Estée Lauder+6.02%Bausch Health (Solta)-5.43%The Beauty Health Company (HydraFacial)+3.65%

The full stock & M&A watch →

FDA Activity — Aesthetic Devices

Monthly 510(k) clearances vs. recalls.

510(k) clearances Recalls

FDA Activity — Aesthetic Devices — Monthly 510(k) clearances vs. recalls.
Month	510(k) clearances	Recalls
Jun '25	0	4
Jul '25	0	1
Sep '25	0	1
Oct '25	0	2
Jan '26	0	1
Feb '26	0	5
Mar '26	0	5
Apr '26	0	19
May '26	7	18
Jun '26	34	8
Jul '26	23	4
Aug '26	5	0

The 50-state regulation tracker →

Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.

The twice-a-week intelligence brief Go Pro · $20/mo →

Steel Partners Offers to Acquire InMode at $16.75 Per Share; Board Evaluates Rival Bids

Share

Discussion

Leave a comment

By the time it's news, it's too late.